Ongoing federal probes shed light on PBM and insurer practices
PhRMA Blog
by
6d ago
The Pharmacy Benefit Manager (PBM) industry continues to face pressure to put an end to the abusive practices that are driving up costs for patients and driving independent pharmacies out of business ..read more
Visit website
Women’s Health Month: A conversation with Sage
PhRMA Blog
by
6d ago
Many women struggle with symptoms of postpartum depression after giving birth, and many can suffer in silence ..read more
Visit website
World Trade Week 2024: Time for a more ambitious U.S. trade agenda
PhRMA Blog
by
6d ago
This week, PhRMA joins workers and businesses across the country in celebrating World Trade Week ..read more
Visit website
How government price setting fails to address systemic health care inequities
PhRMA Blog
by
6d ago
Lowering prescription drug costs for patients and making access to medicines more equitable are two important priorities for America’s biopharmaceutical research companies ..read more
Visit website
Experts discuss the value of IP at Senate Judiciary Committee hearing
PhRMA Blog
by
6d ago
The Senate Judiciary Committee recently hosted a hearing to examine competition in the prescription drug marketplace, with an emphasis on intellectual property (IP) protections ..read more
Visit website
Mental Health Awareness Month: Supporting loved ones and improving mental health in America
PhRMA Blog
by
6d ago
During this month of national awareness, let’s rededicate ourselves to providing the hope and care that’s needed for all Americans to experience mental wellness ..read more
Visit website
How the IRA is more coercive than any European government price setting scheme
PhRMA Blog
by
6d ago
A recent article in Health Affairs Forefront shows how the IRA’s price setting provisions are more coercive than any European country system and threaten access to medicines for millions of Medicare and Medicaid beneficiaries ..read more
Visit website
ICYMI: Innovation transforms lives but misguided federal policies threaten patient outcomes
PhRMA Blog
by
6d ago
This spring, I spoke at Reuters Pharma USA 2024 with Voters for Cures champion Terry Uhl to discuss the regulatory hurdles hindering the development of new, lifesaving medicines ..read more
Visit website
Government price-setting boards: Why Minnesota needs to take a better approach
PhRMA Blog
by
2w ago
There are better ways to lower the cost of prescription drugs that protect access to medicines and the development of new treatments ..read more
Visit website
340B grows and grows, but patients do not see the savings
PhRMA Blog
by
2w ago
The numbers are in and the 340B Drug Pricing Program is the second largest federal drug program for another year in a row. Unfortunately, hospital systems and the chain pharmacies they contract with are exploiting the program to generate massive profits off the backs of hardworking Americans ..read more
Visit website

Follow PhRMA Blog on FeedSpot

Continue with Google
Continue with Apple
OR